Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment

In recent years, and particularly associated with the increase of cancer patients’ life expectancy, the occurrence of cancer treatment sequelae, including cognitive impairments, has received considerable attention. Chemotherapy-induced cognitive impairments (CICI) can be observed not only during pha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Boullon, Raquel Abalo, Álvaro Llorente-Berzal
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9e632277a1814193ae0063e55640b31c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e632277a1814193ae0063e55640b31c
record_format dspace
spelling oai:doaj.org-article:9e632277a1814193ae0063e55640b31c2021-11-12T04:47:12ZCannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment1663-981210.3389/fphar.2021.734613https://doaj.org/article/9e632277a1814193ae0063e55640b31c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.734613/fullhttps://doaj.org/toc/1663-9812In recent years, and particularly associated with the increase of cancer patients’ life expectancy, the occurrence of cancer treatment sequelae, including cognitive impairments, has received considerable attention. Chemotherapy-induced cognitive impairments (CICI) can be observed not only during pharmacological treatment of the disease but also long after cessation of this therapy. The lack of effective tools for its diagnosis together with the limited treatments currently available for alleviation of the side-effects induced by chemotherapeutic agents, demonstrates the need of a better understanding of the mechanisms underlying the pathology. This review focuses on the comprehensive appraisal of two main processes associated with the development of CICI: neuroinflammation and oxidative stress, and proposes the endogenous cannabinoid system (ECS) as a new therapeutic target against CICI. The neuroprotective role of the ECS, well described in other cognitive-related neuropathologies, seems to be able to reduce the activation of pro-inflammatory cytokines involved in the neuroinflammatory supraspinal processes underlying CICI. This review also provides evidence supporting the role of cannabinoid-based drugs in the modulation of oxidative stress processes that underpin cognitive impairments, and warrant the investigation of endocannabinoid components, still unknown, that may mediate the molecular mechanism behind this neuroprotective activity. Finally, this review points forward the urgent need of research focused on the understanding of CICI and the investigation of new therapeutic targets.Laura BoullonLaura BoullonLaura BoullonRaquel AbaloRaquel AbaloRaquel AbaloRaquel AbaloÁlvaro Llorente-BerzalÁlvaro Llorente-BerzalÁlvaro Llorente-BerzalFrontiers Media S.A.articlechemotherapy-induced cognitive impairmentcannabinoid drugsendocannabinoid systemneuroinflammationoxidative stressTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic chemotherapy-induced cognitive impairment
cannabinoid drugs
endocannabinoid system
neuroinflammation
oxidative stress
Therapeutics. Pharmacology
RM1-950
spellingShingle chemotherapy-induced cognitive impairment
cannabinoid drugs
endocannabinoid system
neuroinflammation
oxidative stress
Therapeutics. Pharmacology
RM1-950
Laura Boullon
Laura Boullon
Laura Boullon
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
description In recent years, and particularly associated with the increase of cancer patients’ life expectancy, the occurrence of cancer treatment sequelae, including cognitive impairments, has received considerable attention. Chemotherapy-induced cognitive impairments (CICI) can be observed not only during pharmacological treatment of the disease but also long after cessation of this therapy. The lack of effective tools for its diagnosis together with the limited treatments currently available for alleviation of the side-effects induced by chemotherapeutic agents, demonstrates the need of a better understanding of the mechanisms underlying the pathology. This review focuses on the comprehensive appraisal of two main processes associated with the development of CICI: neuroinflammation and oxidative stress, and proposes the endogenous cannabinoid system (ECS) as a new therapeutic target against CICI. The neuroprotective role of the ECS, well described in other cognitive-related neuropathologies, seems to be able to reduce the activation of pro-inflammatory cytokines involved in the neuroinflammatory supraspinal processes underlying CICI. This review also provides evidence supporting the role of cannabinoid-based drugs in the modulation of oxidative stress processes that underpin cognitive impairments, and warrant the investigation of endocannabinoid components, still unknown, that may mediate the molecular mechanism behind this neuroprotective activity. Finally, this review points forward the urgent need of research focused on the understanding of CICI and the investigation of new therapeutic targets.
format article
author Laura Boullon
Laura Boullon
Laura Boullon
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
author_facet Laura Boullon
Laura Boullon
Laura Boullon
Raquel Abalo
Raquel Abalo
Raquel Abalo
Raquel Abalo
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
Álvaro Llorente-Berzal
author_sort Laura Boullon
title Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
title_short Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
title_full Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
title_fullStr Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
title_full_unstemmed Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
title_sort cannabinoid drugs-related neuroprotection as a potential therapeutic tool against chemotherapy-induced cognitive impairment
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9e632277a1814193ae0063e55640b31c
work_keys_str_mv AT lauraboullon cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT lauraboullon cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT lauraboullon cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT raquelabalo cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT raquelabalo cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT raquelabalo cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT raquelabalo cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT alvarollorenteberzal cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT alvarollorenteberzal cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
AT alvarollorenteberzal cannabinoiddrugsrelatedneuroprotectionasapotentialtherapeutictoolagainstchemotherapyinducedcognitiveimpairment
_version_ 1718431246352121856